References
- AbbottRDSharpDSBurchfieldCMCross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart ProgramAnn Epidemiol19977417249279451
- BarnhamKJMastersCLBushAINeurodegenerative diseases and oxidative stressNat Rev Drug Discov200432051415031734
- BenzieIFFStrainJJThe ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assayAnal Biochem19962397068660627
- BermejoPGómez-SerranillosPSantosJDetermination of malonaldehyde in Alzheimer’s disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid testGerontology199743218229222750
- BerrCBalansardBArnaudJCognitive decline is associated with systemic oxidative stress: the EVA study, Etude du Vieillissement ArteirelJ Am Geriatr Soc20004812859111037017
- CaoGPriorRMeasurement of oxygen radical absorbance capacity in biological samples. Oxidants and antioxidantsMethods Enzymol199929950629916196
- Ceballos-PicotIMansouriaMBNicoleAPeripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer’s type place of the extracellular glutathione peroxidaseFree Radical Biol Med199620579878904299
- CorderEHSaundersAMStrittmatterWJGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset familiesScience199326192138346443
- CorzoLZasRRodríguezSDecreased levels of nitric oxide in different forms od dementiaNeurosci Lett2007420263717556102
- DimopoulosNPiperiCSaloniciotiACharacterization of the lipid profile in dementia and depression in the elderlyJ Geriatr Psychiatry Neurol2007201384417712096
- Feillet-CoudrayCTourtauchauxRNiculescuMPlasma levels of 8-epiPGF2a, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s diseaseFree Radic Biol Med199927463910468223
- FerraraABarrett-ConnorEShanJTotal, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984–1994Circulation19979637439236414
- GalbuseraCFacherisMMagniFIncreased susceptibility to plasma lipid peroxidation in Alzheimer’s disease patientsCurr Alzheimer Res20041103915975074
- GoedertMSpillantiniMGA century of Alzheimer’s diseaseScience20063147778117082447
- GuidiIGalimbertiDLonatiSOxidative imbalance in patients with mild cognitive impairment and Alzheimer’s DiseaseNeurobiol Aging200627262916399211
- KampaMNistikakiATsausisVA new authomated method for determination of the total antioxidant capacity (TAC) of human plasma based on crocin bleaching assayBMC Clin Pathol2002211611882256
- KikuchiATakedaAOnoderaHSystemic increase of oxidative nucleic acid damage in Parkinson’s disease and multiple atrophyNeurobiol Dis20029448
- KivipeltoMHelkalaELLaaksoMPMidlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based studyBMJ200132214475111408299
- KomulainenPLakkaTAKivipeltoMMetabolic syndrome and cognitive function: a population-based follow-up study in elderly womenDement Geriatr Cogn Disord200723293417068394
- LavadosMFariasGRothhammerFApoE alleles and tau markers in pateints with different levels of cognitive impairmentArch Med Res200536474916099324
- LavadosMGuillonMMujicaMCMild cognitive impairment and Alzheimer’s patients disk’lay different levels of redox CSF ironJ Alz Dis20081322532
- Leininger-MullerBJolivaltCBertrandPPackerLChristenYOxidation of human apolipoprotein E: isoforms susceptibility and protection with Ginkgo biloba EGb 761 extractGinkgo biloba Extract (Egb761) Study: Lesson from Cell Biology1998ParisElsevier5768
- MaccioniRBMunozJPBarbeitoLThe molecular bases of Alzheimer’s disease and other neurodegenerative disordersArch Med Res2001323678111578751
- MalliarakiNMpliampliasDKampaMTotal and corrected antioxidant capacity in hemodialyzed patientsBMC Nephrol20034412837136
- McKhannGDrachmanDFolsteinMClinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of the Department Of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology198434939446610841
- MielkeMMZandiPPSjogrenMHigh total cholesterol levels in late-life associated with a reduced risk of dementiaNeurology20056416899515911792
- NotkolaILSulkavaRPekkanenJSerum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s diseaseNeuroepidemiology19981714209549720
- NunomuraAMoreiraPILeeHGNeuronal death and survival under oxidative stress in Alzheimer diseaseCNS Neurol Dis Drug Targets2007641123
- OrdoudiSATsimidouMZCrocin bleaching assay step by step: observations and suggestions for an alternative validated protocolJ Agric Food Chem2006516637116506817
- OuBHampsch-WoodillMPriorRDevelopment and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probeJ Agric Food Chem20014946192611599998
- PanzaFCapursoCD’IntronoATotal cholesterol levels and the risk of mild cognitive impairment and Alzheimer’s diseaseJ Am Geriatr Soc200755133517233704
- PerryGNunomuraAJonesPKOxidative imbalance is a major feature of Alzheimer diseaseCurr Biochem Res200031516
- PulidoRBravoLSaura-CalixtoFAntioxidant activity of dietary polyphenols as determined by a modified ferric reducing/antioxidant power assayJ Agric Food Chem200048339640210956123
- PulidoRJiménez-EscrigAOrensanzLStudy of plasma antioxidant status in Alzheimer’s diseaseEur J Neurol200512531515958093
- RamassamyCKrzywokowskiPBastianettoSPackerLChristenYApolipoprotein E, oxidative stress and EGb 761 in Alzheimer’s disease brainGinkgo biloba Extract (EGb 761) Study: Lesson from Cell Biology1998ParisElsevier6983
- ReisbergBFranssenEHSourenLEProgression of Alzheimer’s disease: variability and consistency: ontogenic models, their applicability and relevanceJ Neural Transm Suppl1998549209850911
- ReitzCTangMXManlyJPlasma lipid levels in the elderly are not associated with the risk of mild cognitive impairmentDement Geriatr Cogn Disord200825232718264008
- RepettoMGReidesCGEvelsonPPeripheral markers of oxidative stress in probable Alzheimer patients (1999)Eur J Clin Invest199929643910411672
- RojoLSjöbergMKHernándezPRoles of cholesterol and lipids in the etiopathogenesis of Alzheimer’s diseaseJ Biomed Biotechnol200620067397617047312
- SatohKSerum lipid peroxide in cerebrovascular disorders determined by a new colorimetric methodClin Chim Acta1978903743719890
- SerraJADominguezROde LustigESParkinson’s disease is associated with oxidative stress: comparison of peripheral antioxidant proles in living Parkinson’s, Alzheimer’s and vascular dementia patientsJ Neural Transm200110811354811725816
- SinclairAJBayerAJohstonJOAltered plasma antioxidant status in subjects with Alzheimer’s disease and vascular dementiaInt J Geriat Psychiatry1998138405
- SolomonAKåreholtINganduTSerum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up studyNeurology200768751617339582
- TubaroFMicossiEUrsiniFThe antioxidant capacity of complex mixtures by kinetic analysis of crocin bleaching inhibitionJ Am Oil Chem Soc1996731739
- ZafrillaPMulcroJXandriJMOxidative stress in Alzheimer patients in differents stages of the diseaseCurr Med Chem20061310758316611085